Literature DB >> 19824825

Revascularization for coronary artery disease: stents versus bypass surgery.

Spencer B King1, John Jeffrey Marshall, Pradyumna E Tummala.   

Abstract

Coronary artery disease (CAD) is one manifestation of ischemic heart disease, which is the leading cause of mortality in the world. In addition to preventive medical therapy and lifestyle changes, consideration of revascularization of obstructed arteries to reduce ischemia, alleviate angina, and improve quality of life is a mainstay of current practice. However, the benefits of different methods of revascularization in particular patient populations are debated. Percutaneous coronary intervention (PCI), which involves placement of intracoronary stents in most patients, is a less invasive procedure than coronary artery bypass graft (CABG) surgery. Although it is generally accepted that patients with single-vessel obstructive CAD are best treated with PCI, patients with multivessel CAD have a higher ischemia burden, a greater risk for developing recurrent ischemic events, and a higher mortality. It is in this patient population where the debate over revascularization with stents versus surgery continues.

Entities:  

Mesh:

Year:  2010        PMID: 19824825     DOI: 10.1146/annurev.med.032309.063039

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  9 in total

1.  Declining in-hospital mortality in patients undergoing coronary bypass surgery in the United States irrespective of presence of type 2 diabetes or congestive heart failure.

Authors:  Mohammad Reza Movahed; Radhakrishnan Ramaraj; Ali Khoynezhad; Mehrnoosh Hashemzadeh; Mehrtash Hashemzadeh
Journal:  Clin Cardiol       Date:  2012-05       Impact factor: 2.882

Review 2.  Biomimetic nanoparticle technology for cardiovascular disease detection and treatment.

Authors:  Joon Ho Park; Diana Dehaini; Jiarong Zhou; Maya Holay; Ronnie H Fang; Liangfang Zhang
Journal:  Nanoscale Horiz       Date:  2019-06-28       Impact factor: 10.989

3.  Neutrophil-derived cathelicidin protects from neointimal hyperplasia.

Authors:  Oliver Soehnlein; Sarawuth Wantha; Sakine Simsekyilmaz; Yvonne Döring; Remco T A Megens; Sebastian F Mause; Maik Drechsler; Ralf Smeets; Stefan Weinandy; Fabian Schreiber; Thomas Gries; Stefan Jockenhoevel; Martin Möller; Santosh Vijayan; Marc A M J van Zandvoort; Birgitta Agerberth; Christine T Pham; Richard L Gallo; Tilman M Hackeng; Elisa A Liehn; Alma Zernecke; Doris Klee; Christian Weber
Journal:  Sci Transl Med       Date:  2011-10-05       Impact factor: 17.956

Review 4.  Gene delivery nanoparticles to modulate angiogenesis.

Authors:  Jayoung Kim; Adam C Mirando; Aleksander S Popel; Jordan J Green
Journal:  Adv Drug Deliv Rev       Date:  2016-11-30       Impact factor: 15.470

Review 5.  Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

6.  Unprotected left main percutaneous coronary intervention in a 108-year-old patient.

Authors:  Afzalur Rahman; Akm Monwarul Islam
Journal:  Korean Circ J       Date:  2014-03-12       Impact factor: 3.243

Review 7.  Preoperative management of antiplatelet drugs for a coronary artery stent: how can we hit a moving target?

Authors:  Thomas R Vetter; James M Hunter; Arthur M Boudreaux
Journal:  BMC Anesthesiol       Date:  2014-08-23       Impact factor: 2.217

Review 8.  Endothelial- and Immune Cell-Derived Extracellular Vesicles in the Regulation of Cardiovascular Health and Disease.

Authors:  Felix Jansen; Qian Li; Alexander Pfeifer; Nikos Werner
Journal:  JACC Basic Transl Sci       Date:  2017-12-25

Review 9.  Applications of Tissue Decellularization Techniques in Ventricular Myocardial Biofabrication.

Authors:  Aravind Krishnan; Hanjay Wang; John Ward MacArthur
Journal:  Front Bioeng Biotechnol       Date:  2022-02-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.